Expert opinion is shifting towards LDL of below 30 as optimal, while this hasn't been definitively proven in clinical trials.

LDL-C is cumulative exposure: lowering it earlier and longer matters most
Reposts an infographic arguing that LDL-C should be seen as plaque-years: every year of elevated LDL adds arterial burden that cannot be undone, so starting treatment at 30 beats starting at 45, and early intervention may matter more than drug strength.


